May 2 |
Axogen, Inc Reports First Quarter 2024 Financial Results
|
May 1 |
AxoGen Q1 2024 Earnings Preview
|
May 1 |
AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
|
Apr 29 |
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
|
Apr 16 |
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
|
Apr 4 |
Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long
|
Mar 9 |
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)
|
Mar 8 |
US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results
|
Mar 6 |
AxoGen files $100M mixed securities shelf
|
Mar 6 |
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript
|